Clinical Trials List
2020-12-01 - 2025-12-31
Phase II
Recruiting5
ICD-10D05.00
Lobular carcinoma in situ of unspecified breast
ICD-10D05.01
Lobular carcinoma in situ of right breast
ICD-10D05.02
Lobular carcinoma in situ of left breast
ICD-10D05.10
Intraductal carcinoma in situ of unspecified breast
ICD-10D05.11
Intraductal carcinoma in situ of right breast
ICD-10D05.12
Intraductal carcinoma in situ of left breast
ICD-10D05.80
Other specified type of carcinoma in situ of unspecified breast
ICD-10D05.81
Other specified type of carcinoma in situ of right breast
ICD-10D05.82
Other specified type of carcinoma in situ of left breast
ICD-10D05.90
Unspecified type of carcinoma in situ of unspecified breast
ICD-10D05.91
Unspecified type of carcinoma in situ of right breast
ICD-10D05.92
Unspecified type of carcinoma in situ of left breast
ICD-9233.0
Carcinoma in situ of breast
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Chi-Cheng Huang Division of General Surgery
- Jiun-I Lai Division of Hematology & Oncology
- Yi-Fang Tsai Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
- Ling-Ming Tseng Division of General Surgery
- 林燕淑 Division of General Surgery
- 邱仁輝 Division of General Surgery
- Jane Wang Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊舜如 Division of Hematology & Oncology
- Kuo-Ting Lee Division of General Surgery
- Yao-Lung Kuo Division of General Surgery
- Zhu-Jun Loh Division of General Surgery
- Ya-Ting Hsu Division of General Internal Medicine
- Jui-Hung Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 周旭桓 Division of General Surgery
- Hsien-Kun Chang Division of Hematology & Oncology
- 阮昱翔 Division of Hematology & Oncology
- Chi-Chang Yu Division of General Surgery
- Wen-Chi Shen Division of Hematology & Oncology
- Pei-Wei Huang Division of Hematology & Oncology
- Wen-Ling Kuo Division of General Surgery
- Mengting Peng Division of Hematology & Oncology
- Chia-Hui Chu Division of General Surgery
- 沈士哲 Division of General Surgery
- Chan-Keng Yang Division of Hematology & Oncology
- 何蕙余 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15-30 participants
-
Global
300 participants
